# Namita A. Goyal, M.D. – FDA Inspection, Jun 23, 2023

Source: https://www.keypedia.com/records/fda_inspections/namita-a-goyal-md/c785c899-f970-45a9-88e3-b20a1a7ab79e
Source feed: FDA_Inspections

> FDA inspection 1209328 of Namita A. Goyal, M.D., June 23, 2023. Classification: Official Action Indicated (OAI). 10 citations under 21 CFR parts 50 and 312. Form 483 issued.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1209328
- Company Name: Namita A. Goyal, M.D.
- Inspection Date: 2023-06-23
- Classification: Official Action Indicated (OAI)
- Classification Code: OAI
- Project Area: Bioresearch Monitoring
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 10

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/theressa-b-smith/80f0c339-7eac-4c73-b9f6-ecb368738fe6)

Company: https://www.keypedia.com/companies/namita-a-goyal-md/60b02d24-42cd-40c3-b9e7-ea2eefeff103

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d